Key facts
- Notable investors include Jolmo Investment, Xingxiang Investment Holding Group, Sanjie Investment Group, Matwings Technology, Shimer Technology — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Lightsyn
- ·The full record, as it builds
Funding rounds
No funding rounds for Lightsyn are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lightsyn
Developer of synthetic biology-based bio-manufacturing designed to enable sustainable production of bioactive compounds and green raw materials. The company offers dual-core technologies, including a microalgae heterotrophic discovery platform and flexible cell factory systems with advanced fermentation and bioengineering capabilities, enabling biotechnology, personal care, food, and agricultural sectors to achieve efficient bio-based production and improved material sustainability.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2023
- Employees
- 24
- Website
- lightsynbio.com/
- Ownership
- Privately Held (backing)
Lightsyn doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lightsyn shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lightsyn in its N-PORT filings yet. We sweep new filings monthly.